Download Free Sample Report

Radioimmunotherapy Market, Global Outlook and Forecast 2023-2030

Radioimmunotherapy Market, Global Outlook and Forecast 2023-2030

  • Published on : 28 October 2023
  • Pages :63
  • Report Code:SMR-7839217

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report aims to provide a comprehensive presentation of the global market for Radioimmunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioimmunotherapy. This report contains market size and forecasts of Radioimmunotherapy in global, including the following market information:
Global Radioimmunotherapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Radioimmunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Non Hodgkin Lymphoma (NHL) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Radioimmunotherapy include Bayer Healthcare Pharmaceuticals, BioSynthema, Clarity Pharmaceuticals, Curasight, Endocyte, Immunomedics, Molecular Insight Pharmaceuticals, Nordic Nanovector and PDL Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioimmunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioimmunotherapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Type, 2022 (%)
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Global Radioimmunotherapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Application, 2022 (%)
Tumor Antigens
Radionuclides
Antibodies
Global Radioimmunotherapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Radioimmunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioimmunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radioimmunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radioimmunotherapy, market overview.
Chapter 2: Global Radioimmunotherapy market size in revenue.
Chapter 3: Detailed analysis of Radioimmunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioimmunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.